MIDAZOLAM VIATRIS 5 mg/ml, solution injectable ou rectale — 10 ampoule(s) en verre de 10 ml

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930206478
  • CIP7 3020647
  • CIS 63736019

What the source publishes

Holder
VIATRIS SANTE
Active ingredients
MIDAZOLAM
Form
solution injectable pour perfusion ou
Package
10 ampoule(s) en verre de 10 ml
Routes
intramusculaire, intraveineuse, rectale, sous-cutanée
Administrative status
authorised
Supply regime
prescription limitée à 4 semaines ; délivrance fractionnée de 7 jours ; liste I ; prescription en toutes lettres sur ordonnance sécurisée
Marketing status
Déclaration de commercialisation
Authorised on
2000-08-09
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930206478
{
  "cis": "63736019",
  "cip7": "3020647",
  "form": "solution injectable pour perfusion ou",
  "name": "MIDAZOLAM VIATRIS 5 mg/ml, solution injectable ou rectale — 10 ampoule(s) en verre de 10 ml",
  "cip13": "3400930206478",
  "holder": "VIATRIS SANTE",
  "routes": [
    "intramusculaire",
    "intraveineuse",
    "rectale",
    "sous-cutanée"
  ],
  "holders": [
    "VIATRIS SANTE"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "33.57",
  "authorisedOn": "2000-08-09",
  "compositions": [
    {
      "name": "MIDAZOLAM",
      "nature": "SA",
      "strength": "5 mg",
      "linkageNumber": "1",
      "substanceCode": "02667",
      "dosageReference": "1 ml",
      "pharmaceuticalElement": "solution"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "prescription limitée à 4 semaines ; délivrance fractionnée de 7 jours ; liste I ; prescription en toutes lettres sur ordonnance sécurisée",
  "dispensingFee": "1.02",
  "medicinePrice": "32.55",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "MIDAZOLAM VIATRIS 5 mg/ml, solution injectable ou rectale",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "10 ampoule(s) en verre de 10 ml",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65 %"
  ],
  "marketingDeclaredOn": "2022-02-17",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "MIDAZOLAM"
  ],
  "authorisationProcedure": "Procédure nationale",
  "prescriptionConditions": [
    "prescription limitée à 4 semaines",
    "délivrance fractionnée de 7 jours",
    "liste I",
    "prescription en toutes lettres sur ordonnance sécurisée"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930206478"